docetaxel molecule

GPTKB entity

Statements (53)
Predicate Object
gptkbp:instanceOf gptkb:chemical_compound
antineoplastic agent
gptkbp:approvedBy 1995
gptkbp:ATCCode gptkb:L01CD02
gptkbp:brand gptkb:Taxotere
gptkbp:CASNumber gptkb:114977-28-5
gptkbp:chemicalFormula C43H53NO14
gptkbp:chirality chiral
gptkbp:contraindication severe liver impairment
gptkbp:derivedFrom paclitaxel
gptkbp:developedBy gptkb:Rhône-Poulenc_Rorer
gptkbp:discoveredIn 1986
gptkbp:eliminationHalfLife 11 hours
https://www.w3.org/2000/01/rdf-schema#label docetaxel molecule
gptkbp:interactsWith CYP3A4 inhibitors
CYP3A4 inducers
gptkbp:IUPACName (2R,3S)-N-carboxy-3-phenylisoserine, N-tert-butyl ester, 13-ester with 5β-20-epoxy-1,2α,4,7β,10β,13α-hexahydroxytax-11-en-9-one 4-acetate 2-benzoate
gptkbp:KEGGID D07775
gptkbp:legalStatus prescription only
gptkbp:mechanismOfAction inhibits microtubule depolymerization
gptkbp:meltingPoint 232–234°C
gptkbp:metabolism liver
gptkbp:molecularWeight 807.88 g/mol
gptkbp:origin semi-synthetic
gptkbp:patentExpired 2010
gptkbp:pregnancyCategory D (US)
gptkbp:PubChem_CID gptkb:CHEMBL92
gptkb:DB01248
148124
gptkbp:riskFactor may cause cancer
toxic to reproduction
gptkbp:routeOfAdministration intravenous
gptkbp:sideEffect gptkb:anemia
nausea
hair loss
peripheral neuropathy
neutropenia
fluid retention
gptkbp:solubility practically insoluble in water
gptkbp:source European yew (Taxus baccata)
gptkbp:storage 2–8°C
gptkbp:structureType taxane
gptkbp:synonym RP 56976
gptkbp:toxicity myelosuppression
gptkbp:UNII 699121PHCA
gptkbp:usedFor gptkb:non-small_cell_lung_cancer
gptkb:cancer
prostate cancer
head and neck cancer
gastric cancer
gptkbp:WHOModelListOfEssentialMedicines included
gptkbp:bfsParent gptkb:E_ring
gptkbp:bfsLayer 7